James R. O’Dell

20.8k total citations · 1 hit paper
154 papers, 8.2k citations indexed

About

James R. O’Dell is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, James R. O’Dell has authored 154 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Rheumatology, 33 papers in Hematology and 31 papers in Immunology. Recurrent topics in James R. O’Dell's work include Rheumatoid Arthritis Research and Therapies (96 papers), Systemic Lupus Erythematosus Research (63 papers) and Autoimmune and Inflammatory Disorders Research (31 papers). James R. O’Dell is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (96 papers), Systemic Lupus Erythematosus Research (63 papers) and Autoimmune and Inflammatory Disorders Research (31 papers). James R. O’Dell collaborates with scholars based in United States, Canada and United Kingdom. James R. O’Dell's co-authors include Ted R. Mikuls, Lynell W. Klassen, Iain B. McInnes, Kaleb Michaud, Larry W. Moreland, V. Michael Holers, Gerald Moore, Claire E. Haire, Steven Wees and William Palmer and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

James R. O’Dell

152 papers receiving 7.8k citations

Hit Papers

Rheumatoid arthritis dise... 2012 2026 2016 2021 2012 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice
    2012 553 citations Tuhina Neogi, Kaleb Michaud et al. Arthritis Care & Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James R. O’Dell United States 48 5.5k 1.8k 1.4k 1.0k 1.0k 154 8.2k
Axel Finckh Switzerland 49 5.1k 0.9× 1.6k 0.9× 1.9k 1.4× 683 0.7× 920 0.9× 230 8.3k
FC Breedveld Netherlands 40 4.1k 0.8× 1.4k 0.8× 1.3k 0.9× 736 0.7× 681 0.7× 102 6.2k
Roberto Caporali Italy 56 5.7k 1.0× 1.7k 1.0× 2.2k 1.6× 855 0.8× 1.1k 1.0× 450 10.4k
M. A. van Leeuwen Netherlands 31 7.7k 1.4× 3.0k 1.7× 1.7k 1.2× 914 0.9× 950 0.9× 39 10.0k
M. H. van Rijswijk Netherlands 37 4.9k 0.9× 1.6k 0.9× 810 0.6× 648 0.6× 655 0.6× 64 6.9k
F. C. Breedveld Netherlands 52 6.9k 1.2× 2.5k 1.4× 2.2k 1.6× 1.5k 1.4× 1.0k 1.0× 119 10.2k
Rieke Alten Germany 45 6.5k 1.2× 2.7k 1.5× 3.3k 2.4× 842 0.8× 929 0.9× 221 9.6k
Johannes C. Nossent Australia 44 4.5k 0.8× 924 0.5× 2.5k 1.8× 888 0.8× 535 0.5× 201 6.8k
Daniel Wendling France 49 5.4k 1.0× 1.5k 0.9× 2.4k 1.8× 538 0.5× 548 0.5× 514 9.1k
Rubén Burgos‐Vargas Mexico 40 5.4k 1.0× 2.3k 1.3× 2.4k 1.8× 538 0.5× 448 0.4× 186 10.2k

Countries citing papers authored by James R. O’Dell

Since Specialization
Citations

This map shows the geographic impact of James R. O’Dell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James R. O’Dell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James R. O’Dell more than expected).

Fields of papers citing papers by James R. O’Dell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James R. O’Dell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James R. O’Dell. The network helps show where James R. O’Dell may publish in the future.

Co-authorship network of co-authors of James R. O’Dell

This figure shows the co-authorship network connecting the top 25 collaborators of James R. O’Dell. A scholar is included among the top collaborators of James R. O’Dell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James R. O’Dell. James R. O’Dell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Androsenko, Maria, Bridget Kramer, Mary T. Brophy, et al.. (2024). Comparison of Gout Flares With the Initiation of Treat‐to‐Target Allopurinol and Febuxostat: A Post‐Hoc Analysis of a Randomized Multicenter Trial. Arthritis & Rheumatology. 76(10). 1552–1559. 1 indexed citations
2.
O’Dell, James R., Maria Androsenko, Mary T. Brophy, et al.. (2023). Determinants of Achieving Serum Urate Goal with Treat‐to‐Target Urate‐Lowering Therapy in Gout. Arthritis & Rheumatology. 76(4). 638–646. 8 indexed citations
3.
England, Bryant R., Punyasha Roul, Harlan Sayles, et al.. (2022). Cause‐Specific Mortality in Patients With Gout in the US Veterans Health Administration: A Matched Cohort Study. Arthritis Care & Research. 75(4). 808–816. 7 indexed citations
4.
5.
6.
Polinski, Kristen J., Ted R. Mikuls, Michael Mähler, et al.. (2019). Anticyclic Citrullinated Peptide Antibodies 3.1 and Anti-CCP-IgA Are Associated with Increasing Age in Individuals Without Rheumatoid Arthritis. The Journal of Rheumatology. 46(12). 1556–1559. 6 indexed citations
7.
England, Bryant R., Martin Bergman, Jeffrey R. Curtis, et al.. (2019). 2019 Update of the American College of Rheumatology Recommended Rheumatoid Arthritis Disease Activity Measures. Arthritis Care & Research. 71(12). 1540–1555. 166 indexed citations
8.
Boers, Maarten, Jasvinder A. Singh, Stacey S. Cofield, et al.. (2018). A Novel Method to Combine Assessment of Benefit and Harm: Outcome Measures in Rheumatology 3×3 Methodology Applied to Two Active Comparator Trials. Arthritis Care & Research. 71(2). 319–322. 3 indexed citations
9.
O’Dell, James R., Stanley Cohen, Carter Thorne, & Joel M. Kremer. (2018). Treatment of rheumatoid arthritis in the USA: premature use of tumor necrosis factor inhibition and underutilization of concomitant methotrexate. Open Access Rheumatology Research and Reviews. Volume 10. 97–101. 2 indexed citations
10.
Jia, Zhenshan, Xiaobei Wang, Xin Wei, et al.. (2018). Micelle-Forming Dexamethasone Prodrug Attenuates Nephritis in Lupus-Prone Mice without Apparent Glucocorticoid Side Effects. ACS Nano. 12(8). 7663–7681. 43 indexed citations
11.
Yu, Yigang, Geoffrey M. Thiele, Michelene Hearth-Holmes, et al.. (2015). Celastrol Inhibits Inflammatory Stimuli-Induced Neutrophil Extracellular Trap Formation. Current Molecular Medicine. 15(4). 401–410. 54 indexed citations
12.
Badamgarav, Enkhe, Joseph D. Croft, James S. Louie, et al.. (2003). Effects of disease management programs on functional status of patients with rheumatoid arthritis. Arthritis Care & Research. 49(3). 377–387. 31 indexed citations
13.
O’Dell, James R.. (2001). TNF-α Inhibition: The Need for a Tumor Necrosis Factor Thermostat. Mayo Clinic Proceedings. 76(6). 573–575. 7 indexed citations
14.
O’Dell, James R.. (2001). How is it best to treat early rheumatoid arthritis patients?. Best Practice & Research Clinical Rheumatology. 15(1). 125–137. 12 indexed citations
15.
Mikuls, Ted R., James R. O’Dell, Gerald Moore, & William Palmer. (1999). Dietary Supplement Use by Rheumatology and Internal Medicine Clinic Patients Results of a Survey Questionnaire. JCR Journal of Clinical Rheumatology. 5(5). 255–258. 3 indexed citations
16.
O’Dell, James R., et al.. (1998). COMBINATION DMARD THERAPY WITH METHOTREXATE (M)-SULFASALAZINE (S)-HYDROXYCHLOROQUINE (H) IN RHEUMATOID ARTHRITIS (RA): CONTINUED EFFICACY WITH MINIMAL TOXICITY AT 5 YEARS. Arthritis & Rheumatism. 41(9). 4 indexed citations
17.
O’Dell, James R., Claire E. Haire, William Palmer, et al.. (1996). Treatment of Rheumatoid Arthritis with Methotrexate Alone, Sulfasalazine and Hydroxychloroquine, or a Combination of All Three Medications. New England Journal of Medicine. 334(20). 1287–1291. 467 indexed citations
18.
O’Dell, James R., et al.. (1984). ANTERIOR TIBIAL MASS: AN UNUSUAL COMPLICATION OF POPLITEAL CYSTS. Arthritis & Rheumatism. 27(1). 113–115. 5 indexed citations
19.
Howells, T. H., et al.. (1964). AN INTRODUCTION TO FBA.1420: A new Non-barbiturate Intravenous Anaesthetic. British Journal of Anaesthesia. 36(5). 295–301. 24 indexed citations
20.
Linton, Samuel & James R. O’Dell. (1959). Prevention of post-operative chest complications.. Anaesthesia. 14(1). 68–75. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Axel Finckh Breakdown of academic impact, for papers by FC Breedveld Breakdown of academic impact, for papers by Roberto Caporali Breakdown of academic impact, for papers by M. A. van Leeuwen Breakdown of academic impact, for papers by M. H. van Rijswijk Breakdown of academic impact, for papers by F. C. Breedveld Breakdown of academic impact, for papers by Rieke Alten Breakdown of academic impact, for papers by Johannes C. Nossent Breakdown of academic impact, for papers by Daniel Wendling Breakdown of academic impact, for papers by Rubén Burgos‐Vargas
Rankless by CCL
2026